Table: begin end state 1 30 non-cytoplasmic 31 52 transmembrane 53 75 cytoplasmic 76 105 transmembrane 106 108 non-cytoplasmic 109 126 transmembrane 127 165 cytoplasmic 166 186 transmembrane 187 205 non-cytoplasmic 206 225 transmembrane 226 233 cytoplasmic 234 255 transmembrane 256 260 non-cytoplasmic 261 284 transmembrane 285 320 cytoplasmic 321 345 transmembrane 346 371 non-cytoplasmic 372 396 transmembrane 397 402 cytoplasmic 403 426 transmembrane 427 435 non-cytoplasmic 436 455 transmembrane 456 481 cytoplasmic
Input: >WP_011371858.1 NCBI__GCF_000012965.1:WP_011371858.1 MGEFFSGVNSFLEAALFFDILFGMVEGVKLPFLVVWLISGGIYLTLLTKFINLRMFKHSF DILRGKYRTVDDVGEISSFGALTTALSATVGLGNIAGVALAVALGGPGATFWMIVAGFLG MSLKFTEVTLSLQHRVFLKDGTVMGGAMEYLSRGLAEKGYAKFGKILSLIFAVFMIGGAI GGGNVFQVSQALGVVSQEVEFFDKFPIIFGILIAVFVGFVIIGGVTRIAKITEFLVPIMA IIYVSASLWILAYHFEKIDDAISIIFHEAFSTSALYGGVAGSIVHGFQRAVFSSEAGIGS SPVAHAPVKTKYPVRQGLVALYEPFIDTIVICTMTALVIVITGVYEHDGAYMALIEAKEG AALTSAAYGTVISWFPIILSISITLFAFSTIIAWAYYGERAWVYLFGSTYSIIYKLSFLL LIIIGTVVNTAVLVDFSFMLFLTMSLPNILGLFILSKDVKRALEEYLVKLKSGELDREAI R
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server